Evidence map›Paper›PMID 36104133›Full record

SynthesisBMJ open2022

Quality assessment and comparative analysis on the recommendations of current guidelines on screening and diagnosis of peripheral arterial disease: a systematic review.

Oliseneku Damien Uyagu, Cosmas Ofoegbu, Joseph Ikhidero, Emeka Chukwuka, Okezie Enwere, Omokharo Ogierakhi, Alex Adelosoye

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Oliseneku Damien UyaguPrimary Health Center, Thulutha Beni Essa, Saudi Arabia Ministry of Health, Riyadh, Saudi Arabia ouyagu@yahoo.com.ORCID 0000-0001-9508-9869
Cosmas OfoegbuPrimary Health Center, Al Lith, Saudi Arabia Ministry of Health, Riyadh, Saudi Arabia.
Joseph IkhideroDepartment of Internal Medicine-Cardiology Unit, Tathleeth General Hospital, Tathleeth, Saudi Arabia Ministry of Health, Riyadh, Saudi Arabia.
Emeka ChukwukaDepartment of Clinical Pathology/Hematology, Maternity and Children's Hospital, Al Mubaraz, Al Hasa, Saudi Arabia Ministry of Health, Riyadh, Saudi Arabia.
Okezie EnwereDepartment of Internal Medicine, Tathleeth General Hospital, Tathleeth, Saudi Arabia Ministry of Health, Riyadh, Saudi Arabia.
Omokharo OgierakhiPrimary Health Center, Alzazia, Saudi Arabia Ministry of Health, Riyadh, Saudi Arabia.
Alex AdelosoyeBoard for Family Medicine Program, Al Mukhatat Primary Health Care Center, Saudi Arabia Ministry of Health, Riyadh, Saudi Arabia.
Ministry of Health · SAMaternity and Children's Hospital · SASaudi Center for Disease Prevention and Control · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThere are several clinical practice guidelines available for peripheral artery disease (PAD). The paucity of strong evidence is known to give room for variations in recommendations across guidelines, with attendant confusion among clinicians in clinical practice. This study aims to conduct a quality assessment and comparative analysis on PAD screening and diagnostic recommendations in PAD management. SELECTION: Clinical practice guidelines written after 2010 and on or before 2020 were targeted. An exhaustive search was conducted through the major medical databases and websites of specialist international organisations of interest, and selection was made using our inclusion/exclusion criteria.

settingGlobal. All guidelines written in English were included in this study. SELECTED GUIDELINES: Nine guidelines were selected. OUTCOMES: The primary outcomes were the guidelines' quality and variations in screening and diagnostic recommendations in the selected guidelines.

resultsRegarding quality, the guidelines had the lowest scores across the applicability and stakeholder involvement domains with means (SD) of 62 (9.9) and 65.3 (13), respectively. The highest score was clarity of presentation, with a mean (SD) of 86.8 (5.1). Also, the trend showed guideline quality scores improved over time. The guidelines unanimously offered to screen 'high-risk' patients, although there were some discrepancies in the appropriate age range and unavailability of strong evidence backing this recommendation. The guidelines harmoniously adopted the Ankle-Brachial Index as the initial diagnostic investigation of choice. However, concerning further diagnostic investigations and imaging, we found several discrepancies among the recommendations in the absence of strong evidence.

conclusionThough the quality of the guidelines is shown to be improving over time, they perform poorly in stakeholder involvement and applicability domains, which could be influencing interest in research revolving around screening and diagnostic recommendations. Involving primary care providers and the public can be a possible solution. PROSPERO REGISTRATION NUMBER: CRD42020219176.

Indexed as

Peripheral Arterial DiseaseDatabases, FactualHumanscardiologypreventive medicinevascular medicinevascular surgery

Identifiers

PMID36104133
PMCPMC9476116
OpenAlexW4295681652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.